NYSE:HNICommercial Services
HNI (HNI) Stock May Still Be Below Fair Value On Sales
HNI stock has delivered a solid 54.9% gain over the past three years, yet the current valuation checks and recent share price at US$39.69 still point to a company that screens as undervalued rather than fully priced in.
HNI is up 54.9% over three years, which suggests the stock has already rewarded patient holders while still leaving the question of how much value is left on the table.
Future revenue and cash flow expectations can support the current share price, but any pressure on margins...